Dey Indranil
President and CEO
Dey Indranil has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Dey Indranil is listed as President and CEO at Bluejay Diagnostics, Inc. Inside the rolling window, Dey Indranil reported 1 open-market purchase totaling $25K in BJDX and no open-market sales.
Companies traded
Other insiders at BJDX
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dey Indranil made?
Dey Indranil has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Dey Indranil trade?
Dey Indranil has filed SEC Form 4 disclosures for 1 company, including BJDX.
When was Dey Indranil's most recent SEC Form 4 filing?
Dey Indranil's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Dey Indranil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dey Indranil is listed as President and CEO.
What is Dey Indranil's total buy and sell value in the current window?
Inside the rolling retention window, Dey Indranil bought $25K and sold $0 based on SEC Form 4 filings.
What was Dey Indranil's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,500 BJDX shares on 2026-03-14, worth $25K, per SEC Form 4 filings.